AGENT CAPABLE OF MODULATING A GLYCOSPHINGOLIPID-ASSOCIATED ACTIVITY THUS AFFECTING AN IMMUNE DISORDER

摘要

The use of an agent in the manufacture of a medicament to affect an immune disorder is described. The agent is capable of modulating a glycosphingolipid associated activity. The modulation of the glycosphingolipid associated activity affects an immune disorder.